Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 14/20 | 0.74 |
| ▸ | HDAC1 | Q13547 | 7/20 | 0.74 |
| ▸ | HDAC2 | Q92769 | 7/20 | 0.74 |
| ▸ | BRD2 | P25440 | 2/20 | 0.74 |
| ▸ | BRD3 | Q15059 | 2/20 | 0.74 |
| ▸ | SMCHD1 | A6NHR9 | 1/20 | 0.74 |
| ▸ | MYO1G | B0I1T2 | 1/20 | 0.74 |
| ▸ | AIP | O00170 | 1/20 | 0.74 |
| ▸ | AP3B1 | O00203 | 1/20 | 0.74 |
| ▸ | PSMD11 | O00231 | 1/20 | 0.74 |
| ▸ | CDC7 | O00311 | 1/20 | 0.74 |
| ▸ | SAP18 | O00422 | 1/20 | 0.74 |
| ▸ | KPNA3 | O00505 | 1/20 | 0.74 |
| ▸ | PPP6C | O00743 | 1/20 | 0.74 |
| ▸ | TCERG1 | O14776 | 1/20 | 0.74 |
| ▸ | UBE2L6 | O14933 | 1/20 | 0.74 |
| ▸ | PPP1R12A | O14974 | 1/20 | 0.74 |
| ▸ | U2SURP | O15042 | 1/20 | 0.74 |
| ▸ | SETD1A | O15047 | 1/20 | 0.74 |
| ▸ | ARPC1B | O15143 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9999402 | 0.93 | BRD4 (0.71) | BRD4HDAC1HDAC2BRD2BRD3 | |
| SCHEMBL16758250 | 0.93 | BRD4 (0.75) | BRD4HDAC1HDAC2BRD2BRD3 | |
| SCHEMBL16758384 | 0.92 | BRD4 (0.74) | BRD4HDAC1HDAC2BRD2BRD3 | |
| SCHEMBL9998823 | 0.91 | BRD4 (0.77) | BRD4HDAC1HDAC2BRD2BRD3 | |
| SCHEMBL9999159 | 0.91 | BRD4 (0.77) | BRD4HDAC1HDAC2BRD2BRD3 | |
| SCHEMBL16758213 | 0.90 | BRD4 (0.72) | BRD4HDAC1HDAC2BRD2BRD3 | |
| SCHEMBL9998882 | 0.90 | BRD4 (0.72) | BRD4HDAC1HDAC2BRD2BRD3 | |
| SCHEMBL16758215 | 0.90 | BRD4 (0.76) | BRD4HDAC1HDAC2BRD2BRD3 | |
| SCHEMBL16771524 | 0.90 | BRD4 (0.79) | BRD4HDAC1HDAC2BRD2BRD3 | |
| SCHEMBL9998877 | 0.89 | BRD4 (0.75) | BRD4HDAC1HDAC2BRD2BRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9085582-B2 | Benzotriazolodiazepine compounds inhibitors of bromodomains | GLAXOSMITHKLINE LLC (US) | 2015-07-21 | — | — | US | claimed |
| EP-2585465-B1 | BENZOTRIAZOLODIAZEPINE COMPOUNDS INHIBITORS OF BROMODOMAINS | GLAXOSMITHKLINE LLC (US) | 2014-11-12 | — | — | EP | claimed |
| EP-2585465-A1 | BENZOTRIAZOLODIAZEPINE COMPOUNDS INHIBITORS OF BROMODOMAINS | GlaxoSmithKline LLC (US) | 2013-05-01 | — | — | EP | claimed |
| US-20130079335-A1 | Benzotriazolodiazepine Compounds Inhibitors Of Bromodomains | GLAXOSMITHKLINE LLC | 2013-03-28 | — | — | US | claimed |
| WO-2011161031-A1 | BENZOTRIAZOLODIAZEPINE COMPOUNDS INHIBITORS OF BROMODOMAINS | GLAXOSMITHKLINE LLC (US) | 2011-12-29 | — | — | WO | claimed |
| US-9085582-B2 | Benzotriazolodiazepine compounds inhibitors of bromodomains | GLAXOSMITHKLINE LLC (US) | 2015-07-21 | — | — | US | disclosed |
| US-9085582-B2 | Benzotriazolodiazepine compounds inhibitors of bromodomains | GLAXOSMITHKLINE LLC (US) | 2015-07-21 | — | — | US | disclosed |
| EP-2585465-B1 | BENZOTRIAZOLODIAZEPINE COMPOUNDS INHIBITORS OF BROMODOMAINS | GLAXOSMITHKLINE LLC (US) | 2014-11-12 | — | — | EP | disclosed |
| EP-2585465-B1 | BENZOTRIAZOLODIAZEPINE COMPOUNDS INHIBITORS OF BROMODOMAINS | GLAXOSMITHKLINE LLC (US) | 2014-11-12 | — | — | EP | disclosed |
| EP-2585465-A1 | BENZOTRIAZOLODIAZEPINE COMPOUNDS INHIBITORS OF BROMODOMAINS | GlaxoSmithKline LLC (US) | 2013-05-01 | — | — | EP | disclosed |
| US-20130079335-A1 | Benzotriazolodiazepine Compounds Inhibitors Of Bromodomains | GLAXOSMITHKLINE LLC | 2013-03-28 | — | — | US | disclosed |
| US-20130079335-A1 | Benzotriazolodiazepine Compounds Inhibitors Of Bromodomains | GLAXOSMITHKLINE LLC | 2013-03-28 | — | — | US | disclosed |
| WO-2011161031-A1 | BENZOTRIAZOLODIAZEPINE COMPOUNDS INHIBITORS OF BROMODOMAINS | GLAXOSMITHKLINE LLC (US) | 2011-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079335-A1 | Benzotriazolodiazepine Compounds Inhibitors Of Bromodomains | BRD4, BRD3, BRD2 | BRD4 1/4885HDAC1 107/4885HDAC2 100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.